Trenton, New Jersey - According to the New Jersey Economic Development Authority, Healthcare executives-turned-entrepreneurs Tara Zedayko and Jessica Chu co-founded pet health technology startup Bark Biome, which does business as DIG Labs, armed with a background in life sciences, a passion for helping their canine companions, and a mission to improve the lives of pets all over the world. Today, the Princeton-based company is nearing the launch of its first app and crediting support from the New Jersey Economic Development Authority (NJEDA) with helping to reach this milestone.DIG Labs, which was established last year, markets, manufactures and sells personalized canine supplements. The company’s new app, which is set to go live in November, will offer contactless assessment and tracking of a dog's internal health in real time, starting with a single photo. The app will allow pet parents to collect, analyze, and translate insights into actionable health plans.

Washington D.C.- According to Route Fifty, from increasing the capacity of VPN infrastructure to rethinking the IT help desk, chief information officers had to address new challenges during the early days of the coronavirus pandemic.

Washington D.C. - According to the U.S. Food and Drug Administration, the agency approved Inmazeb (atoltivimab, maftivimab, and odesivimab-ebgn), a mixture of three monoclonal antibodies, as the first FDA-approved treatment for Zaire ebolavirus (Ebola virus) infection in adult and pediatric patients.“Today’s action demonstrates the FDA’s ongoing commitment to responding to public health threats—both domestically and abroad—on the basis of science and data,” said FDA Commissioner Stephen M. Hahn, M.D. “This approval was made possible because of our steadfast dedication to facilitate the development of safe and effective treatments for infectious diseases as part of our vital public health mission.”

Westerville, Ohio- According to SSTI, the Economic Development Administration’s Office of Innovation and Entrepreneurship (OIE) has announced $25 million for the Scaling Pandemic Resilience through Innovation and Technology (SPRINT) Challenge utilizing funding from the CARES Act. EDA is seeking applications from organizations working to address the economic, health and safety risks caused by the coronavirus pandemic through entrepreneurship and innovation. This national competition is designed to support the development, creation, or expansion of programs that accelerate technology-based economic development (TBED) in pursuit of vibrant, innovative economies and economic growth, and respond to the challenges caused by the coronavirus pandemic. 

Atlantic City, New Jersey - According to Stockton University, a dozen people spoke at the groundbreaking for the Phase II Residence Hall at Stockton University Atlantic City on Wednesday, and each represented a crucial element in making the project a reality. “I can’t wait to see this take shape,” Gov. Phil Murphy told the approximately 150 guests at the outdoor ceremony held in O’Donnell Park, across from the Stockton Atlantic City campus. “It will create good jobs today, help prepare the next generation, and diversify the economy of Atlantic City.”
Murphy said the future of Atlantic City is powered not just by gaming and entertainment, but by academia, entrepreneurship and the arts.

Trenton, New Jersey - According to the New Jersey Economic Development Authority, the agency approved entering into a Memorandum of Understanding (MOU) with the Commission on Science, Innovation and Technology (CSIT) to develop and implement two programs designed to further research and development (R&D) within the state’s clean technology startup community. CSIT approved entrance into this MOU at its Board meeting this past Friday.The NJEDA previously entered into an MOU with the New Jersey Board of Public Utilities (NJBPU) for the NJBPU to provide $1.25 million in funding for the creation of a Cleantech Seed Grant Program and a Clean Technology R&D Asset Voucher Program. Under the MOU approved today, NJEDA and CSIT will collaborate to develop these programs, both of which are important steps toward achieving Governor Phil Murphy’s goal of attaining 100 percent clean energy for New Jersey by 2050.
The Cleantech Seed Grant Program will provide grants for R&D activities to very early-stage, New Jersey-based clean technology companies. These grants will help businesses to continue their work into the proof of concept and prototyping stages, at which point they can more readily attract outside investors and, in some cases, begin to generate revenue.

Washington D.C.-According to Route Fifty, Chatbots were the most likely automated technology to be deployed by state governments to respond to the coronavirus, according to a NASCIO survey.

Automated technologies that some state agencies were skeptical of using in the past have seen widespread adoption during the government response to the coronavirus pandemic, according to state chief information officers.

Kansas City, Missouri - According to Startup Catalyst Brief, a growing trend in entrepreneur ecosystem development has been quietly emerging over the last few years: an increase in the number of foundations that not only recognize the vital role entrepreneurs play in building communities but that also are willing to fund entrepreneur ecosystem development.In fact, a report published by the International Economic Development Council (IEDC) in 2016 noted that 51% of the survey respondents received funding from community foundations. Nationally, we are seeing an uptick in the number of calls we are fielding from foundations who wish to engage in the entrepreneurial development space.

Washington D.C.-According to PHRMA, America’s biopharmaceutical companies are at the heart of a robust research and development (R&D) ecosystem that develops more innovative medicines than any other country in the world. The ongoing development of new life-saving and life-improving medicines would not be possible without a robust pipeline of science, technology, engineering and math (STEM) workers at all levels.

Washington D.C.-According to the Information Technology & Innovation Foundation, Congressman David Cicilline (D-RI), chairman of the House Judiciary Subcommittee on Antitrust, Commercial, and Administrative Law, issued a staff report yesterday on competition and the digital economy. The report is the product of more than a year of investigations and seven congressional hearings, including testimony this summer from the CEOs of Amazon, Apple, Facebook, and Google.The report represents a long-overdue examination of how antitrust law should be applied to the largest Internet companies. It is important that Congress and regulators understand both the challenges and the opportunities information technology poses for competition policy. Unfortunately, many of the report’s conclusions reflect the majority Democrats’ starting point: a hostility toward big companies, a strong suspicion that their success comes from anticompetitive behavior rather than from providing the best services and constantly improving them, and a view that antitrust policy should protect competitors. So, rather than carefully applying antitrust law to address clear problems, Cicilline and his Democratic colleagues would seek to restructure markets to achieve significantly more competition. Such a broad attack would harm consumer welfare and inhibit innovation.

Washington D.C.-According to The Conversation, to address climate change over the coming decades, all nations will need to transition to energy resources that emit less carbon. This transformation, already underway, will require many new technologies.The United States is a world leader in scientific research and technological development. But new inventions have to be brought to market and then widely adopted to have a deep impact. And in the clean energy field, the United States doesn’t do as well at making that happen as one might be expect, given its strength in basic research.
The energy transition might stall if the U.S. doesn’t overcome this problem, endangering human health and the environment. Research I carried out with Jetta L. Wong, the founding director of the Office of Technology Transitions at the U.S. Department of Energy, suggests that creating a new foundation that would be authorized by Congress to work closely with the Energy Department could help.

New Brunswick, New Jersey - According to Newswise, Rutgers Cancer Institute of New Jersey has received a $1.6 million, five-year grant from the National Cancer Institute (1R25CA247785-0) to support the Rutgers Youth Enjoy Science (RUYES) Program. RUYES seeks to increase the diversity of the biomedical, cancer research workforce in order to reduce cancer disparities in both New Jersey and across the United States. This program utilizes innovative approaches and newly established partnerships both within Rutgers and in the surrounding community to provide RUYES participants a comprehensive learning experience in cancer research, career development, and community engagement.

Trenton, New Jersey - According to the New Jersey Business & Industry Association, legislation that would ease some considerable tax pain for business owners got off to a positive start this week.The intent of bill S-3011 aims to avoid a massive unemployment insurance (UI) payroll tax increase in 2021, by way of more manageable payroll tax increases spread out over time when the business climate has improved.
The bill was released by the Senate Labor Committee on Thursday by a 5-0 margin. And its sponsor, committee Chair Fred Madden, D-4, said his first call was going to be to Senate President Steve Sweeney “to get this moving as fast as we can.”

Newark, New Jersey - According to Rutgers University, Precision medicine is a rapidly growing approach to health care that focuses on finding treatments and interventions that work for people based on their genetic makeup, rather than their symptoms. Zeeshan Ahmed, director of the new Ahmed Lab at Rutgers Institute for Health, Health Care Policy and Aging Research, discusses the future of precision medicine, what needs to be done to successfully analyze the data necessary to develop individualized treatments and the role genetics play during the COVID-19 pandemic.

Washington D.C. - According to the U.S. Food & Drug Administration, it announced on October 8 that it has awarded six new clinical trial research grants to principal investigators from academia and industry totaling over $16 million over the next four years. These trial research grants, awarded through the Congressionally-funded Orphan Products Grants Program, enhance the development of medical products for patients with rare diseases.